Vaxtex Cotfab Financials
| VCL Stock | 0.87 0.01 1.16% |
Vaxtex | Select Account or Indicator |
Please note, the presentation of Vaxtex Cotfab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vaxtex Cotfab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vaxtex Cotfab's management manipulating its earnings.
Vaxtex Cotfab Stock Summary
Vaxtex Cotfab competes with VIP Clothing, Consolidated Construction, Reliance Industrial, Sarthak Metals, and Hindustan Construction. Vaxtex Cotfab is entity of India. It is traded as Stock on NSE exchange.Specialization | Consumer Discretionary, Consumer Durables & Apparel |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE098201036 |
| Business Address | J-03 Tejendra Arcade, |
| Sector | Textiles, Apparel & Luxury Goods |
| Industry | Consumer Discretionary |
| Benchmark | Dow Jones Industrial |
| Website | vaxtexcotfabltd.com |
| Phone | 91 95 3766 9940 |
You should never invest in Vaxtex Cotfab without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Vaxtex Stock, because this is throwing your money away. Analyzing the key information contained in Vaxtex Cotfab's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Vaxtex Cotfab Key Financial Ratios
There are many critical financial ratios that Vaxtex Cotfab's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Vaxtex Cotfab Limited reports annually and quarterly.| Revenue | 166.2 M | ||||
| Gross Profit | (52.06 M) | ||||
| EBITDA | (86.16 M) | ||||
| Net Income | (88.34 M) | ||||
| Total Asset | 488.72 M |
Vaxtex Cotfab Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 216.9M | 239.9M | 694.8M | 488.7M | 562.0M | 590.1M | |
| Other Current Liab | 983.8K | 5.6M | 111.0M | 7.0M | 8.1M | 7.7M | |
| Net Debt | 101.8M | 73.0M | 51.0M | 114.9M | 132.2M | 138.8M | |
| Retained Earnings | 6.2M | 3.2M | 14.5M | (147.3M) | (132.6M) | (126.0M) | |
| Accounts Payable | 21.9M | 52.6M | 294.0M | 176.0M | 202.3M | 212.5M | |
| Cash | 1.1M | 1.5M | 930K | 224K | 201.6K | 191.5K | |
| Net Receivables | 97.9M | 68.6M | 182.2M | 157.1M | 180.7M | 189.7M | |
| Inventory | 17.1M | 54.1M | 13.4M | 2.1M | 2.5M | 2.3M | |
| Other Current Assets | 61.6M | 66.2M | 450.8M | 247.7M | 284.8M | 299.1M | |
| Total Liab | 128.1M | 136.3M | 460.0M | 300.8M | 345.9M | 363.2M | |
| Total Current Assets | 129.9M | 200.1M | 657.6M | 418.2M | 480.9M | 504.9M | |
| Short Term Debt | 2.1M | 14.2M | 61K | 15.3M | 17.5M | 10.2M | |
| Long Term Debt | 100.9M | 60.3M | 51.8M | 99.9M | 89.9M | 64.9M | |
| Net Invested Capital | 191.7M | 178.1M | 286.7M | 303.1M | 348.5M | 257.9M | |
| Short Long Term Debt | 2.1M | 14.2M | 167K | 15.3M | 13.7M | 10.4M | |
| Net Working Capital | 104.5M | 126.5M | 251.7M | 220.0M | 253.0M | 169.8M |
Vaxtex Cotfab Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Revenue | 261.5M | 619.1M | 756.2M | 166.2M | 191.1M | 309.9M | |
| Gross Profit | 26.9M | 77.8M | 53.1M | (52.4M) | (47.2M) | (44.8M) | |
| Operating Income | 12.9M | 27.1M | 1.1M | (54.7M) | (49.2M) | (46.7M) | |
| Ebit | 12.9M | 30.9M | 1.1M | (87.7M) | (78.9M) | (75.0M) | |
| Ebitda | 14.4M | 33.9M | 3.9M | (86.2M) | (77.5M) | (73.7M) | |
| Cost Of Revenue | 234.6M | 541.3M | 703.2M | 218.7M | 251.4M | 277.3M | |
| Income Before Tax | 2.6M | 20.1M | 11.6M | (88.3M) | (79.5M) | (75.5M) | |
| Net Income | 1.8M | 14.9M | 11.3M | (88.3M) | (79.5M) | (75.5M) | |
| Income Tax Expense | 843.2K | 5.2M | 269K | 1.4M | 1.6M | 1.5M | |
| Interest Expense | 10.7M | 10.6M | 6.3M | 658K | 756.7K | 718.9K | |
| Net Interest Income | (10.5M) | (7.0M) | (6.3M) | (658K) | (756.7K) | (794.5K) |
Vaxtex Cotfab Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Vaxtex Cotfab Limited. It measures of how well Vaxtex is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Vaxtex Cotfab brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Vaxtex had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Vaxtex Cotfab has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 24.0M | (37.0M) | 40.7M | 11.3M | 13.0M | 13.6M | |
| Change In Cash | (791.9K) | 355.0K | (564K) | (706K) | (635.4K) | (603.6K) | |
| Free Cash Flow | (6.9M) | 18.2M | (118.8M) | (131.4M) | (118.2M) | (112.3M) | |
| Other Non Cash Items | 10.2M | 7.6M | (16.1M) | (77.5M) | (69.7M) | (66.3M) | |
| Capital Expenditures | 16.2M | 3.6M | 231K | 141.4M | 162.7M | 170.8M | |
| Net Income | 2.6M | 20.1M | 11.6M | (88.3M) | (79.5M) | (75.5M) | |
| End Period Cash Flow | 1.1M | 1.5M | 930K | 224K | 201.6K | 191.5K | |
| Depreciation | 1.5M | 3.0M | 2.8M | 1.5M | 1.8M | 1.7M | |
| Investments | 24.0M | (10.6M) | 3.4M | (31.8M) | (28.6M) | (27.2M) | |
| Change To Netincome | 10.9M | 11.1M | 7.6M | 7.7M | 8.9M | 8.8M |
Vaxtex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vaxtex Cotfab's current stock value. Our valuation model uses many indicators to compare Vaxtex Cotfab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaxtex Cotfab competition to find correlations between indicators driving Vaxtex Cotfab's intrinsic value. More Info.Vaxtex Cotfab Limited is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vaxtex Cotfab's earnings, one of the primary drivers of an investment's value.Vaxtex Cotfab Limited Systematic Risk
Vaxtex Cotfab's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vaxtex Cotfab volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Vaxtex Cotfab Limited correlated with the market. If Beta is less than 0 Vaxtex Cotfab generally moves in the opposite direction as compared to the market. If Vaxtex Cotfab Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vaxtex Cotfab Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vaxtex Cotfab is generally in the same direction as the market. If Beta > 1 Vaxtex Cotfab moves generally in the same direction as, but more than the movement of the benchmark.
Vaxtex Cotfab Limited Total Assets Over Time
Vaxtex Cotfab January 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Vaxtex Cotfab help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vaxtex Cotfab Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vaxtex Cotfab Limited based on widely used predictive technical indicators. In general, we focus on analyzing Vaxtex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vaxtex Cotfab's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.27 | |||
| Information Ratio | 0.0225 | |||
| Maximum Drawdown | 10.26 | |||
| Value At Risk | (4.85) | |||
| Potential Upside | 4.63 |
Complementary Tools for Vaxtex Stock analysis
When running Vaxtex Cotfab's price analysis, check to measure Vaxtex Cotfab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxtex Cotfab is operating at the current time. Most of Vaxtex Cotfab's value examination focuses on studying past and present price action to predict the probability of Vaxtex Cotfab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxtex Cotfab's price. Additionally, you may evaluate how the addition of Vaxtex Cotfab to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |